Karyopharm Therapeutics (NASDAQ:KPTI – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($2.32) EPS for the quarter, missing analysts’ consensus estimates of ($1.37) by ($0.95), FiscalAI reports. The business had revenue of $33.43 million for the quarter, compared to the consensus estimate of $32.19 million. Here are the key takeaways [...]
Karyopharm Therapeutics (NASDAQ:KPTI) Announces Quarterly Earnings Results
Source: Bbns
Read Full Story →
